Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.57 |
| ▸ | C3AR1 | Q16581 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 6/20 | 0.53 |
| ▸ | PDE4A | P27815 | 3/20 | 0.51 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.51 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.51 |
| ▸ | PADI1 | Q9ULC6 | 2/20 | 0.51 |
| ▸ | PADI4 | Q9UM07 | 2/20 | 0.51 |
| ▸ | PADI2 | Q9Y2J8 | 2/20 | 0.51 |
| ▸ | PADI6 | Q6TGC4 | 1/20 | 0.51 |
| ▸ | PADI3 | Q9ULW8 | 1/20 | 0.51 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.51 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.51 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.51 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.51 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | HPGDS | O60760 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1980150 | 1.00 | ITGB3 (0.57) | ITGB3ITGA2BC3AR1CA2PDE4A | |
| SCHEMBL1980652 | 1.00 | ITGB3 (0.57) | ITGB3ITGA2BC3AR1CA2PDE4A | |
| SCHEMBL607886 | 0.95 | ITGB3 (0.60) | ITGB3ITGA2BC3AR1CA2PDE4A | |
| SCHEMBL607885 | 0.95 | ITGB3 (0.60) | ITGB3ITGA2BC3AR1CA2PDE4A | |
| SCHEMBL29775626 | 0.90 | ITGB3 (0.53) | ITGB3ITGA2BC3AR1CA2GRIN1 | |
| SCHEMBL7390292 | 0.90 | ITGB3 (0.55) | ITGB3ITGA2BC3AR1CA2ERAP2 | |
| SCHEMBL6810961 | 0.90 | ITGB3 (0.55) | ITGB3ITGA2BC3AR1CA2ERAP2 | |
| SCHEMBL22312697 | 0.90 | ITGB3 (0.55) | ITGB3ITGA2BC3AR1CA2ERAP2 | |
| SCHEMBL4987446 | 0.89 | C3AR1 (0.72) | ITGB3ITGA2BC3AR1CA2ERAP2 | |
| SCHEMBL27772282 | 0.89 | C3AR1 (0.72) | ITGB3ITGA2BC3AR1CA2ERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025034569-A9 | STING INHIBITORS AND METHODS OF USING THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025034569-A2 | STING INHIBITORS AND METHODS OF USING THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 2025-02-13 | — | — | WO | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20220089549-A1 | INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF | UNIV MASSACHUSETTS (US) | 2022-03-24 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| EP-0552516-B1 | Aqueous synthetic organ-extracts | RIEMSCHNEIDER RANDOLPH DR DR P (DE) | 1997-09-10 | — | — | EP | disclosed |
| EP-0552516-A1 | Aqueous synthetic organ-extracts | SCHÀLKE & MAYR GMBH (DE) | 1993-07-28 | — | — | EP | disclosed |
| WO-1993010802-A1 | AQUEOUS SYNTHETIC ORGAN EXTRACTS | RIEMSCHNEIDER RANDOLPH (DE) | 1993-06-10 | — | — | WO | disclosed |
| EP-0543997-A1 | NOVEL METHOTREXATE DERIVATIVE | Chugai Seiyaku Kabushiki Kaisha (JP) | 1993-06-02 | — | — | EP | disclosed |
| EP-0178911-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1992-01-22 | — | — | EP | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0178911-A2 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1986-04-23 | — | — | EP | disclosed |
| US-4325961-A | FLUOROMETHYLHISTIDINE, ESTERS, AND SALTS | MERCK & CO., INC. (US) | 1982-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089549-A1 | INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF | PADI2, PADI1, PADI4 | ITGB3 4259/4885ITGA2B 4564/4885C3AR1 2475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.